Omniscope
PrivateLast Round
Early Funding
Feb 25, 2025
Total Funding Raised
$6.28M
Company Overview
Omniscope operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was an Early Funding round in February 2025.
Omniscope is a biotechnology company that develops an artificial intelligence-based platform to decode the immune system for diagnostic and therapeutic purposes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Sports & Fitness, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Omniscope Comparables
Compare Omniscope with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SoundHound AI, Inc. | 76% | |
| TruDiagnostic | 72% | |
| GlycanAge | 66% |
For institutional investors. Book with your work email.
Omniscope Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Feb 25, 2025 | ||||
| Grant | Jan 1, 2024 | ||||
| Seed | Jun 1, 2023 | ||||
| Grant | Sep 1, 2022 | ||||
| Seed | Oct 1, 2021 |
For institutional investors. Book with your work email.
Omniscope Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Commission | Grant |
| FoundersX Ventures | Early Funding, Seed |
| Buenavista Equity Partners | Early Funding |
| Barça Innovation Hub | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Partnered with barnaclínic+ on AI-driven immune decoding for sports medicine.
- Apr 22, 2026
Launched AI-driven immune decoding technology with barnaclínic+.
For institutional investors. Book with your work email.
Omniscope Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Omniscope's valuation, stock price, and market status.
Is Omniscope a public or private company?
Omniscope is a private company.
What is the current stock price of Omniscope?
Omniscope is a private company, so its shares have no public market price. Caplight tracks Omniscope's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Omniscope worth (valuation)?
Valuation information for Omniscope is not publicly available.
Can I buy Omniscope stock?
Omniscope shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Omniscope's last funding round?
Omniscope's most recent funding round was Early Funding on February 25, 2025.
Who are the main investors in Omniscope?
Key investors in Omniscope include FoundersX Ventures, Buenavista Equity Partners.
Will Omniscope IPO soon?
No public IPO plans have been announced for Omniscope.
How can I track Omniscope secondary market activity?
Caplight tracks bids, offers, and trades in Omniscope's shares on secondary markets.